Understanding healthcare burden and treatment patterns among young adults with schizophrenia

Journal of Medical Economics
Ahong HuangAbigail Nash

Abstract

Schizophrenia is a serious public health problem that affects ∼1% of the US population. To examine treatment patterns and evaluate healthcare resource utilization (HRU) and costs among young adults (18-35 years) with schizophrenia who were early in the disease. Patients aged 18-64 years with ≥2 schizophrenia diagnoses in the identification period (January 1, 2012-September 30, 2015) and continuous enrollment for ≥12 months pre- and post-index date were identified from the OptumInsight Clinformatics DataMart. Demographics, clinical characteristics, HRU, costs, and treatment patterns were compared between schizophrenia and non-schizophrenia "controls" cohorts and between young (18-35 years) and older adults (36-64 years) with schizophrenia. Among 9,889 schizophrenia patients, 23.70% were young adults (aged 18-35), had higher all-cause per-patient-per-year (PPPY) costs ($22,338 vs $7,332; p < .0001), higher inpatient costs ($8,857 vs $1,289; p < .0001), and longer inpatient length-of-stay (LOS) (5.0 vs 0.4 days, p < .0001; adjusted incidence rate ratio [aIRR] = 12.8; 95% confidence interval [CI] = 11.5-14.3) than controls. Among young adults with schizophrenia, there were more mental-health-related and fewer non-mental-health-rela...Continue Reading

References

Apr 9, 2009·Cost Effectiveness and Resource Allocation : C/E·Nicolas M FuriakSteven D Culler
Jun 22, 2012·The International Journal of Neuropsychopharmacology·W Wolfgang Fleischhacker, Hiroyuki Uchida
Feb 23, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Rebecca SchennachHans-Jürgen Möller
Aug 31, 2013·JAMA : the Journal of the American Medical Association·Jeffrey A LiebermanHoward H Goldman
Oct 24, 2013·Annals of General Psychiatry·José M OlivaresAndreas Schreiner
Nov 28, 2013·Nordic Journal of Psychiatry·Thomas R EinarsonMichiel E H Hemels
Jun 27, 2014·Journal of Managed Care Pharmacy : JMCP·Elizabeth J CampagnaElaine H Morrato
Dec 3, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·S HeresR Vauth
Jan 19, 2016·Lancet·Michael J OwenPreben B Mortensen
May 3, 2016·The Journal of Clinical Psychiatry·Martin CloutierEric Wu
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·H Y ChongC F Chiou
Oct 13, 2016·The Journal of Clinical Psychiatry·Christoph U CorrellJohn M Kane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here